The band is connected to a port placed under the skin in the abdomen
After two weeks with no adverse effects, increase to the standard dose
For patients who are needle-averse, who have difficulty adhering to strict dosing windows, or whose weight management goals do not require reductions of 20% or more, an oral GLP-1 weight loss regimen may be a well-matched and more sustainable choice
This chart is meant to give a general idea of what to expect
Part D coverage for obesity medications is expected to begin in January 2027 under the CMS BALANCE Model, with eligible beneficiaries paying $50/month
Novonesis leverages the microbiome for next-gen healthy longevity solutions Experts highlight that through technological, medicinal, and nutritional innovations, we are consistently living longer than any generation before